The ‘East Asian Paradox’ refers to a unique risk-benefit trade-off observed in Asian patients for thrombosis versus bleeding, ...

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after succe ...

Compared with thrombotic stroke, hemorrhagic stroke has more than double the odds of diagnostic delay in pregnant and postpartum patients.

Patients in the endovascular therapy group achieved greater functional outcomes at 90 days. 2. Endovascular therapy resulted in significantly decreased disability and overall mortality. Evidence ...

Early findings suggest that IA tenecteplase after successful thrombectomy is safe and improves functional outcomes over standard care in anterior circulation LVO stroke.

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

Some clinicians prefer aspirin when balancing bleeding risk with the indication for an anticoagulant, Barnes said, reasoning ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

A spontaneous coronary artery dissection, or SCAD, leads to bleeding inside the artery wall. A survivor shares her symptoms.

Previous published models for predicting the risk of symptomatic intracranial hemorrhage (sICH) after reperfusion therapy were primarily developed for anterior circulation stroke patients. In external ...